PAS
HALO icon

Point72 Asia (Singapore)’s Halozyme HALO Stock Holding History

Point72 Asia (Singapore)’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,590
Closed -$268K – 1210
2024
Q1 		$268K Buy
+6,590
New +$247K 0.07% 322

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Point72 Asia (Singapore)'s HALO Position: Q2 2024 in Review

Point72 Asia (Singapore) sold out of Halozyme (HALO) in Q2 2024, closing a stake of 6,590 shares — an estimated $268K sold.

Point72 Asia (Singapore) first reported a position in HALO in Q1 2024 and held it in 1 quarter. The position peaked at $268K in Q1 2024. 460 funds tracked by Wall St. Rank hold HALO as of Q2 2024.

  • Point72 Asia (Singapore) reported no remaining Halozyme position as of Q2 2024 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 6,590 Halozyme shares in Q2 2024, an estimated $268K.
  • Point72 Asia (Singapore) first reported a position in Halozyme in Q1 2024 and held it in 1 quarter.
  • Point72 Asia (Singapore)'s Halozyme position peaked at $268K in Q1 2024.
  • 460 funds tracked by Wall St. Rank held Halozyme as of Q2 2024.

Based on Point72 Asia (Singapore)'s 13F filing for Q2 2024, filed 14 Aug 2024.